132 related articles for article (PubMed ID: 2702573)
21. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
22. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
[TBL] [Abstract][Full Text] [Related]
23. Plasma and tissue CEA and TPA markers in operable breast cancer. Preliminary results.
Saccani Jotti G; Bombardieri E; Fontanesi M; Becchi G; Bocchi P; Palli D; Rusca M; Rusconi A; Pizzorno B; Tardini A
Tumori; 1988 Dec; 74(6):681-8. PubMed ID: 3232213
[TBL] [Abstract][Full Text] [Related]
24. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
Lüthgens M; Schlegel G
Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
[TBL] [Abstract][Full Text] [Related]
25. Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer.
Mathew J; Prinsloo P; Agrawal A; Gutteridge E; Marenah C; Robertson JF; Cheung KL
Breast; 2014 Oct; 23(5):567-72. PubMed ID: 24874285
[TBL] [Abstract][Full Text] [Related]
26. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
Leonardo E; Dogliotti C; Mancuso M; Sanfilippo B; Oliaro A
Minerva Med; 1986 Mar; 77(11):375-9. PubMed ID: 3703330
[TBL] [Abstract][Full Text] [Related]
27. Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.
Molina R; Jo J; Zanón G; Filella X; Farrus B; Muñoz M; Latre ML; Pahisa J; Velasco M; Fernandez P; Estapé J; Ballesta AM
Br J Cancer; 1996 Oct; 74(7):1126-31. PubMed ID: 8855986
[TBL] [Abstract][Full Text] [Related]
28. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
29. CA 15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse.
Vizcarra E; Lluch A; Cibrián R; Jarque F; García-Conde J
Oncology; 1994; 51(6):491-6. PubMed ID: 7970492
[TBL] [Abstract][Full Text] [Related]
30. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer.
Buccheri G; Ferrigno D; Vola F
Lung Cancer; 1993 Oct; 10(1-2):21-33. PubMed ID: 8069601
[TBL] [Abstract][Full Text] [Related]
31. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
[TBL] [Abstract][Full Text] [Related]
32. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
33. [Serum carcinoembryonic antigen levels in breast cancer].
Haim N; Bartal AH; Cohen Y; Cordova T; Ayalon D
Harefuah; 1980 Feb; 98(4):152-4. PubMed ID: 7399356
[No Abstract] [Full Text] [Related]
34. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
35. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F
Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052
[TBL] [Abstract][Full Text] [Related]
36. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
[TBL] [Abstract][Full Text] [Related]
37. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
38. [CEA and TPA in cancer of the breast. Findings and criteria of use].
Torres Avisbal M; Ruíz de Almodovar Rivera JM; Villalba Moreno J; Olea Serrano N; Padilla Bolivar O; Pedraza Muriel V
Rev Esp Oncol; 1985; 32(2):265-80. PubMed ID: 3843460
[TBL] [Abstract][Full Text] [Related]
39. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
40. Pre-operative tumour marker levels in patients with breast cancer and their prognosis.
van Dalen A
Tumour Biol; 1990; 11(4):189-95. PubMed ID: 2371496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]